- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
LDL-C /HDL-C ratio better predicts coronary artery disease severity in STEMI patients: Study
China: In patients with STEMI, the LDL-C/HDL-C ratio is more correlated with the severity of coronary artery disease as compared to the ratios of non-HDL-C and LDL-C, reveals a study published in BMC Cardiovascular Disorders.
The researchers further add that "the LDL-C/HDL-C ratio can better predict whether patients with chest pain are ST-segment elevation myocardial infarction (STEMI) and better evaluate the severity of coronary artery disease."
In the occurrence of atherosclerosis, the increase of low-density lipoprotein cholesterol (LDL-C) is widely accepted as an important factor. The guideline in recent years has recommended non-high-density lipoprotein cholesterol (non-HDL-C) as a secondary target for lipid-lowering therapy. But despite increases in the research on the relationship between LDL-C/HDL-C and atherosclerosis, which index is most closely related to the severity of acute STEMI remains undetermined.
Against the above background, Po Gao, Hefei Hospital Affiliated to Anhui Medical University, Hefei, China, and colleagues aimed to explore the evaluative effect of the above two indicators on the severity of coronary artery disease in STEMI patients, both weighing which of the two indicators evaluates severity more effectively, and identifying the boundary value that requires intervention.
For this purpose, the researchers included 901 patients who received coronary angiography due to chest pain. 772 patients with STEMI represented the test group and 129 patients with basically normal coronary angiography represented the control group. Measurement of their fasting blood lipids and other indicators was done after admission, and the severity of coronary artery disease was determined using the Gensini score.
Based on the study, the researchers reported the following findings:
· LDL-C/HDL-C and non-HDL-C indexes were statistically different between the two patient groups.
· In the test group, total cholesterol (TC), triglycerides (TG), LDL-C, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, arteriosclerosis index (AI), and LDL-C/HDL-C all correlated with the patients' Gensini score.
· After applying the stepwise method of multiple linear regression analysis, LDL-C/HDL-C had the most correlation with the patient's Gensini score.
· ROC curve analysis suggested that LDL-C/HDL-C can predict whether patients with chest pain are STEMI.
· When the cutoff value is 2.15, sensitivity is 0.845, and specificity is 0.202, LDL-C/HDL-C is an effective indicator for predicting whether patients with chest pain have STEMI.
The researchers conclude, "we found that LDL-C/HDL-C works more effectively than non-HDL-C in evaluating the severity of coronary artery disease in STEMI patients and also in predicting whether patients with chest pain are STEMI."
Reference:
Gao, P., Wen, X., Ou, Q. et al. Which one of LDL-C /HDL-C ratio and non-HDL-C can better predict the severity of coronary artery disease in STEMI patients. BMC Cardiovasc Disord 22, 318 (2022). https://doi.org/10.1186/s12872-022-02760-0
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751